Phd student Muna Abedrabbo recently received the 20th Annual OTS Meeting 2024 best poster award. This price is awarded once a year by the Oligonucleotide Therapeutics Society in Canada.

In this meeting Muna presented her PhD project. The poster focused mainly on the Leavitt Lab's progress in screening the antisense oligonucleotides designed by the Radboud group on PDE primary astrocytes from their PDE mouse model. They hypothesize that lowering the levels of lysine intermediate metabolites by blocking an upstream enzyme in the lysine catabolic pathway, a Aminoadipic Semialdehyde Synthase, using antisense oligonucleotides, will lead to a correction of the disease phenotype.

As seen in the picture of all the awardees of the meeting, Muna standing first on the left side.

On behalf of the CHARLIE consortium we congratulate Muna with this award and we are very happy with her being part of our consortium.